Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia

BACKGROUND: Waldenström macroglobulinemia (WM) is preceded by asymptomatic WM (AWM), for which the risk of progression to overt disease is not well defined. METHODS: We studied 439 patients with AWM, who were diagnosed and observed at Dana-Farber Cancer Institute between 1992 and 2014. RESULTS: Duri...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Bustoros, Mark, Sklavenitis-Pistofidis, Romanos, Kapoor, Prashant, Liu, Chia-Jen, Kastritis, Efstathios, Zanwar, Saurabh, Fell, Geoffrey, Abeykoon, Jithma P., Hornburg, Kalvis, Neuse, Carl Jannes, Marinac, Catherine R., Liu, David, Soiffer, Jenny, Gavriatopoulou, Maria, Boehner, Cody, Cappuccio, Joseph M., Dumke, Henry, Reyes, Kaitlen, Soiffer, Robert J., Kyle, Robert A., Treon, Steven P., Castillo, Jorge J., Dimopoulos, Meletios A., Ansell, Stephen M., Trippa, Lorenzo, Ghobrial, Irene M.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2019
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6544461/
https://ncbi.nlm.nih.gov/pubmed/30990729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.00394
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars